Director/PDMR Shareholding

One Health Group PLC

01 March 2024

 

One Health Group PLC

PDMR Share Dealing

TR1 - Notification of Major Holdings

1^st March 2024

One Health Group PLC ("One Health" or the "Company") announces that following the exercise of options granted under the One Health Group Share Option Plan ("Share Options") Derek Bickerstaff, a director and Chair of One Health and who controls over 3% of the Total Voting Rights in the Company, has notified One Health that his percentage interest in Ordinary Shares has reduced to approximately 56.87% of the issued share capital of the Company.  Further details are contained in the disclosure form in Appendix 1.

This announcement contains inside information for the purposes of Article 7 of EU Regulation
596/2014. Which is part of the United Kingdom domestic law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)("UK MAR").

The directors of One Health accept responsibility for this announcement.

Enquiries

One Health Group plc	Via Square 1 Consulting
Oberon Capital (AQSE Corporate Adviser and Broker) Nick Lovering, Mike Seabrook	020 3179 5300
Square 1 Consulting David Bick	020 7929 5599

Appendix 1

TR-1: standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:			ONE HEALTH GROUP PLC 131 Psalter Lane Sheffield S11 8UX LEI: 984500DC689F5BAD8732
1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights						X
Other (please specify) iii:
3. Details of person subject to the notification obligation iv
Name			Derek Richard Bickerstaff
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.) v
Name			As above
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached vi:			29th February 2024
6. Date on which issuer notified (DD/MM/YYYY):			29th February 2024
7. Total positions of person(s) subject to the notification obligation
	% of voting rights attached to shares (total of 8. A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)		Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached	56.87%			56.87%	6,000,000
Position of previous notification (if applicable)	57.09%			57.09%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)		Number of voting rights ix					% of voting rights
		Direct (DTR5.1)		Indirect  (DTR5.2.1)			Direct (DTR5.1)		Indirect (DTR5.2.1)
GB00BNNT0595		6,000,000					56.87%
SUBTOTAL 8. A		6,000,000					56.87%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument		Expiration date x	Exercise/ Conversion Period xi			Number of voting rights that may be acquired if the instrument is exercised/converted.			% of voting rights
			SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument	Expiration date x		Exercise/ Conversion Period xi		Physical or cash Settlement xii			Number of voting rights	% of voting rights
					SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii				x
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv
Name xv	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information xvi

Place of completion	Aquis (AQSE)
Date of completion	29th February 2024

 

END